Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N study

Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N study

Background: Nimotuzumab is an anti-epidermal growth factor receptor monoclonal antibody which can be added to chemoradiotherapy (CRT) to improve efficacy for management of locally advanced squamous cell carcinoma of the head and neck (LASCCHN). We prospectively evaluated the efficacy and safety of n...

Full description

Bibliographic Details
Main Authors: Ashok Kumar, Nilotpal Chakravarty, Sharad Bhatnagar, G S Chowdhary
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Series:South Asian Journal of Cancer
Subjects:
Locally advanced head-and-neck carcinoma
monoclonal antibody
nimotuzumab
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=2;spage=108;epage=111;aulast=Kumar

Internet

http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=2;spage=108;epage=111;aulast=Kumar

Similar Items